Biomark Diagnostics Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Mar '26 Mar 10, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020 - 2016
Market Capitalization	38	14	17	10	11	21	Upgrade
Market Cap Growth	225.54%	-15.29%	61.96%	-7.18%	-45.46%	140.92%	Upgrade
Enterprise Value	38	15	18	12	12	21	Upgrade
Last Close Price	0.37	0.14	0.19	0.13	0.14	0.27	Upgrade
PS Ratio	674.73	145.04	152.12	100.50	356.91	-	Upgrade
PB Ratio	121.88	12.85	-40.73	-13.42	-24.67	-386.98	Upgrade
P/TBV Ratio	121.88	12.85	-	-	-	-	Upgrade
EV/Sales Ratio	-	154.52	161.35	110.73	393.16	-	Upgrade
Debt / Equity Ratio	2.75	0.64	-2.54	-1.44	-3.09	-12.70	Upgrade
Net Debt / Equity Ratio	0.21	-0.78	-2.28	-1.37	-2.49	-1.61	Upgrade
Net Debt / EBITDA Ratio	-0.06	0.67	-0.82	-0.86	-1.24	-0.12	Upgrade
Net Debt / FCF Ratio	-0.05	1.24	-1.41	-1.72	-1.25	-0.16	Upgrade
Asset Turnover	0.06	0.07	0.18	0.14	0.04	-	Upgrade
Quick Ratio	1.20	2.14	0.16	0.06	0.31	0.98	Upgrade
Current Ratio	1.20	2.14	0.16	0.08	0.33	1.00	Upgrade
Return on Equity (ROE)	-	-340.70%	-	-	-	-	Upgrade
Return on Assets (ROA)	-81.70%	-60.59%	-117.29%	-104.38%	-66.20%	-80.77%	Upgrade
Return on Capital Employed (ROCE)	-218.40%	-107.60%	1099.30%	197.40%	4328.70%	-3366.60%	Upgrade
Earnings Yield	-2.74%	-8.62%	-5.75%	-11.94%	-9.27%	-3.57%	Upgrade
FCF Yield	-3.31%	-4.90%	-3.98%	-5.96%	-8.06%	-2.64%	Upgrade
Buyback Yield / Dilution	84.66%	-6.67%	-2.97%	-6.22%	-6.31%	-2.82%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.